Shares of Novartis fell more than 3% on Monday after its cholesterol drug failed in a closely watched study, dealing ‌a blow ...

Novo Nordisk A/S stopped two more trials for its experimental heart disease medicine, in a further blow to the drug’s ...

“What we do is we offer structured exercise programmes in community settings to people with diverse chronic illnesses, so we ...

AIIMS probes a 15-year-old’s death after years of congenital heart disease care, highlighting the challenges of treating ...

The suggestion came from a friend, who encouraged Sharron to ask about a CT calcium score. The scan can detect plaque ...

A Chinese medical team achieved a world first by successfully using an AI-driven, ultrasound-guided ...

From aortic stenosis to the five variants of a common liver disease, Mayo Clinic scientists recently published research papers in three major journals.

Nearly 1 in 3 adults is sleep-deprived, and now it counts as a core heart-health risk.

A routine heart check gave Sharron Yaxley the all-clear. One extra test revealed a potentially deadly problem, and may have ...

Researchers found that urolithin A improved relaxation in engineered human heart tissue and reduced several hallmarks of ...

Novartis faces second trial setback as heart drug pelacarsen fails to reduce heart attacks or strokes, shares drop.

In the UK alone, researchers estimated that second-hand smoke was responsible for 6,100 deaths in 2023 - making it deadlier ...